About Namocell
Namocell is a company based in Mountain View (United States) founded in 2014 by Jessica Zhou was acquired by Bio-Techne in June 2022. Namocell offers products and services including Pala Cell Sorter, Hana Cell Sorter, RNAscope ISH Probes, and Simple Plex Immunoassays. Namocell operates in a competitive market with competitors including NanoCellect Biomedical, ThinkCyte, Singulex, Cell Microsystems and Silicon Biosystems, among others.
- Headquarter Mountain View, United States
- Founders Jessica Zhou
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Bio-Techne
(Jun 21, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Namocell
Namocell offers a comprehensive portfolio of products and services, including Pala Cell Sorter, Hana Cell Sorter, RNAscope ISH Probes, and Simple Plex Immunoassays.
Device for fast and gentle single cell sorting and dispensing.
Instrument for simple single cell isolation in research applications.
Tools for spatial biology and molecular detection in diagnostics.
Kits for efficient protein analysis in immunoassays.
Funding Insights of Namocell
Detailed funding history for Namocell
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Namocell
Namocell has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bio-Techne.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of biotech reagents, instruments and clinical diagnostic products
|
Locked | Locked | Locked |
Investor details for Namocell
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Namocell
Investment portfolio details for Namocell
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Namocell
Detailed financials for Namocell
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Namocell Comparisons
Peer comparison for Namocell
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Namocell
Namocell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NanoCellect Biomedical, ThinkCyte, Singulex, Cell Microsystems and Silicon Biosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Develops flow cytometry and cell sorting technology
|
|
| Locked | Locked | Locked |
Cell analysis and sorting technologies are developed with AI integration.
|
|
| Locked | Locked | Locked |
Single-molecule counting technology is developed for cardiovascular biomarker detection.
|
|
| Locked | Locked | Locked |
Developer of a technology to isolate and recover single cells for molecular analysis
|
|
| Locked | Locked | Locked |
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
|
|
| Locked | Locked | Locked |
Cell and molecular-based diagnostics for cancer management are developed.
|
Detailed competitors of Namocell
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Namocell
Complete news archive for Namocell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Namocell
Namocell was founded in 2014.
Namocell is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Instruments for single-cell sorting were developed by Namocell, founded in 2014 and based in Mountain View, United States. The flagship product, Nami, employs microfluidics and fluorescence to enable gentle cell sorting directly into 96- and 384-well plates. Applications encompass single T-cell and B-cell receptor sequencing, circulating tumor cell isolation, single-cell RNADNA sequencing, monoclonal antibody development, cell line development, and transfection pool enrichment within the biotechnology sector.
Namocell's top competitors include NanoCellect Biomedical, ThinkCyte and Silicon Biosystems.
Namocell offers Pala Cell Sorter, Hana Cell Sorter, RNAscope ISH Probes, and Simple Plex Immunoassays.
Namocell has 1 investor. Key investors include Bio-Techne.